Improved oxygenation following methylprednisolone therapy and survival in paediatric acute respiratory distress syndrome

BACKGROUND: Methylprednisolone remains a commonly used ancillary therapy for paediatric acute respiratory distress syndrome (PARDS), despite a lack of level 1 evidence to justify its use. When planning prospective trials it is useful to define response to therapy and to identify if there is differen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Mitting, Rebecca B., Ray, Samiran, Raffles, Michael, Egan, Helen, Goley, Paul, Peters, Mark, Nadel, Simon
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6879165/
https://ncbi.nlm.nih.gov/pubmed/31770398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0225737
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars